Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve the unaudited financial ....
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has informed BSE that its Board of Directors will meet on July 31, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY2026). The filing is a standard regulatory disclosure under SEBI LODR Regulation 29. The trading window for insiders remains closed from July 1, 2025 until 48 hours after the results are announced.
No direct impact on shareholders — this is a routine pre-results announcement. Investors should watch for the actual Q1 numbers on July 31 for clues on revenue growth, margins, and order book trends.